Obesity is expected to hinder efferocytosis due to ADAM17-mediated cleavage of the MER tyrosine kinase receptor, producing soluble MER (sMER) that disrupts MERTK binding to cell death markers. This evidence concerns the gene ADAM17 and obesity due to melanocortin 4 receptor deficiency.